Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kinnate Biopharma (KNTE)
NASDAQ:KNTE
Holding KNTE?
Track your performance easily
See the Price Targets and Ratings of:
KNTE Analyst Ratings
Hold
0 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
KNTE Stock 12 Month Forecast
Average Price Target
$2.00
▼(-24.53% Downside)
| Highest Price Target$2.00 | Average Price Target$2.00 | Lowest Price Target$2.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
William Blair
Downgraded
02/16/24
Wedbush
Reiterated
01/17/24
Piper Sandler
$4
Hold
50.94%
Upside
Assigned
11/10/23
Piper Sandler Sticks to Its Hold Rating for Kinnate Biopharma (KNTE)
Leerink Partners
$4
Buy
50.94%
Upside
Reiterated
11/10/23
Promising Drug Developments and Robust Financial Position: A Buy Rating for Kinnate Biopharma
H.C. Wainwright
―
Hold
―
Downgraded
09/19/23
Kinnate Biopharma (KNTE) was downgraded to a Hold Rating at H.C. Wainwright
Jefferies
$2
Buy
-24.53%
Downside
Assigned
09/18/23
Kinnate Biopharma price target lowered to $2 from $31 at JefferiesKinnate Biopharma price target lowered to $2 from $31 at Jefferies
Goldman Sachs
―
Buy
―
Reiterated
05/11/23
Goldman Sachs Keeps Their Buy Rating on Kinnate Biopharma (KNTE)
Best Analysts Covering Kinnate Biopharma
Which Analyst Should I Follow If I Want to Buy KNTE and Sell After:
1 Month
xxx
Success Rate
5/17 ratings generated profit
Average Return
-3.14%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 29.41% of your transactions generating a profit, with an average return of -3.14% per trade.
3 Months
xxx
Success Rate
4/17 ratings generated profit
Average Return
-6.20%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 23.53% of your transactions generating a profit, with an average return of -6.20% per trade.
1 Year
Success Rate
2/17 ratings generated profit
Average Return
-37.03%
reiterated a buy rating a year ago
Copying Andrew Berens's trades and holding each position for 1 Year would result in 11.76% of your transactions generating a profit, with an average return of -37.03% per trade.
2 Years
xxx
Success Rate
2/17 ratings generated profit
Average Return
-51.36%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 11.76% of your transactions generating a profit, with an average return of -51.36% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
KNTE Analyst Recommendation Trends
Rating
Sep 23
Nov 23
Jan 24
Feb 24
Apr 24
Strong Buy
4
4
2
1
0
Buy
1
1
1
0
0
Hold
4
6
7
5
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
11
10
6
4
Each month's total comprises the sum of three months' worth of ratings.
KNTE Financial Forecast
KNTE Stock Forecast FAQ
What is KNTE’s average 12-month price target, according to analysts?
Based on analyst ratings, Kinnate Biopharma’s 12-month average price target is $2.00.
What is KNTE’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for KNTE, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is KNTE a Buy, Sell or Hold?
Kinnate Biopharma has a consensus rating of Hold which is based on 0 buy ratings, 2 hold ratings and 0 sell ratings.
What is Kinnate Biopharma’s price target?
The average price target for Kinnate Biopharma is $2.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $2.00 ,the lowest forecast is $2.00. The average price target represents -24.53% Decrease from the current price of $2.65.
The highest analyst price target is $2.00 ,the lowest forecast is $2.00. The average price target represents -24.53% Decrease from the current price of $2.65.
What do analysts say about Kinnate Biopharma?
Kinnate Biopharma’s analyst rating consensus is a Hold. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of KNTE?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.